The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis

Oncogene

Volumn 21, Issue 47, 2002, Pages 7195-7204

  Liu, Gang ^a   Chen, Xinbin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Apoptosis; FDXR; p53; p63; p73; ROS

Indexed keywords

CYTOCHROME P450; DOXORUBICIN; FERREDOXIN REDUCTASE; FLUOROURACIL; GENE PRODUCT; HISTONE H3; HISTONE H4; HYDROGEN PEROXIDE; PROTEIN P53; PROTEIN P63; PROTEIN P73; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TETRACYCLINE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; ELECTRON TRANSPORT; GENE ACTIVITY; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MITOSIS INHIBITION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SENSITIZATION;

APOPTOSIS; CELL CYCLE; DNA-BINDING PROTEINS; DOXORUBICIN; FERREDOXIN-NADP REDUCTASE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; NUCLEAR PROTEINS; OXIDATIVE STRESS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RESPONSE ELEMENTS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0037126392     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205862     Document Type: Article

References (41)

1. Akman SA, Doroshow JH, Burke TG and Dizdaroglu M. (1992). Biochemistry, 31, 3500-3506.
2. Allen RG and Tresini M. (2000). Free Radic. Biol. Med., 28, 463-499.
3. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B. (1998). Science, 282, 1497-1501.
4. Chandra J, Samali A and Orrenius S. (2000). Free Radic. Biol. Med., 29, 323-333.
5. Chen H, Lin RJ, Xie W, Wilpitz D and Evans RM. (1999). Cell, 98, 675-686.
6. Chen J, Willingham T, Shuford M, Bruce D, Rushing E, Smith Y and Nisen PD. (1996a). Oncogene, 13, 1395-1403.
7. Chen X. (1999). Mol. Med. Today, 5, 387-392.
8. Chen X, Bargonetti J and Prives C. (1995). Cancer Res., 55, 4257-4263.
9. Chen X, Ko LJ, Jayaraman L and Prives C. (1996b). Genes Dev., 10, 2438-2451.
10. Dohn M, Jiang J and Chen X. (2001a). Oncogene, 20, 6503-6515.
11. Dohn M, Zhang S and Chen X. (2001b). Oncogene, 20, 3193-3205.
12. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
13. Hanukoglu I and Gutfinger T. (1989). Eur. J. Biochem., 180, 479-484.
14. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
15. Hermeking H, Lengauer C, Polyak K, He T-C, Zhang L, Thiagalingam S, Kinzler KW and Vogelstein B. (1997). Mol. Cell, 1, 3-11.
16. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
17. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, Kelso GF, Smith RA, Kinzler KW and Vogelstein B. (2001). Nat. Med., 7, 1111-1117.
18. Irwin MS and Kaelin WG. (2001). Cell Growth Differ., 12, 337-349.
19. Kaelin Jr WG. (1999). J. Natl. Cancer Inst., 91, 594-598.
20. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
21. Kramer RE, Du Bois RN, Simpson ER, Anderson CM, Kashiwagi K, Lambeth JD, Jefcoate CR and Waterman MR. (1982). Arch. Biochem. Biophys., 215, 478-485.
22. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
23. Muller JJ, Lapko A, Bourenkov G, Ruckpaul K and Heinemann U. (2001). J. Biol. Chem., 276, 2786-2789.
24. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R. (1989). J. Virol., 63, 4417-4421.
25. Nakano K and Vousden KH. (2001). Mol. Cell, 7, 683-694.
26. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
27. Szak ST, Mays D and Pietenpol JA. (2001). Mol. Cell. Biol., 21, 3375-3386.
28. Urnov FD and Wolffe AP. (2001). Oncogene, 20, 2991-3006.
29. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
30. Waldman T, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 5187-5190.
31. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ and Harris CC. (1999). Proc. Natl. Acad. Sci. USA, 96, 3706-3711.
32. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701-704.
33. Yang A, Kaghad M, Caput D and McKeon F. (2002). Trends Genet, 18, 90-95.
34. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. (1998). Mol. Cell., 2, 305-316.
35. Yang A and McKeon F. (2000). Nat. Rev. Mol. Cell. Biol., 1, 199-207.
36. Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B. (2001). Mol. Cell., 7, 673-682.
37. Zhu J and Chen X. (2000). Mol. Cell. Biol., 20, 5602-5618.
38. Zhu J, Jiang J, Zhou W and Chen X. (1998a). Cancer Res., 58, 5061-5065.
39. Zhu J, Jiang J, Zhou W, Zhu K and Chen X. (1999). Oncogene, 18, 2149-2155.
40. Zhu J, Zhang S, Jiang J and Chen X. (2000). J. Biol. Chem., 275, 39927-39934.
41. Zhu J, Zhou W, Jiang J and Chen X. (1998b). J. Biol. Chem., 273, 13030-13036.